SERMO Drug Ratings platform houses 3M+ data points — 6 highlights

Written by Megan Wood | April 10, 2018 | Print  |

SERMO, a global physician social network, reported its Drug Ratings platform surpassed 3 million data points.

Here are six highlights.

1. SERMO Drug Ratings allows physicians to share their prescription drug reviews and ratings with each other.

2. The 3 million data points include ratings and comments on 2,100-plus pharmaceutical brands.

3. As of March, the platform held 625,000 individual ratings submitted by physicians.

4. The platform also houses 35,000-plus unique comments on physicians' opinions on pharmaceuticals.

5. More than 40,000 physicians have submitted ratings and more than 60,000 have leveraged the platform.

6. Eighty-three percent of 2,900 physicians polled by SERMO said the opinion or feedback of another physician changed their view of a drug.

More articles on practice management:
Saving pediatric pain patients from the opioid epidemic
OrthoAtlanta opens 14th location by Atlanta Braves park: 5 notes
Palmetto Bone & Joint opens new $9M outpatient clinic: 4 points

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months